Gold Prices Close Higher on July 18, 2026... Pure Gold 3.75g Purchase Price at 837,000 Won, Caution Advised on Investment Volatility
As of July 18, 2026, domestic precious metal prices announced by Gold Price.com showed an upward trend, continuing from the previous trading day. ■ Pure Gold (3

As of July 18, 2026, domestic precious metal prices announced by Gold Price.com showed an upward trend, continuing from the previous trading day.
■ Pure Gold (3.75g) — Buy: 837,000 won / Sell: 723,000 won The pure gold purchase price rose by 9,000 won and the selling price by 8,000 won compared to the previous trading day.
■ 18K Gold (3.75g) — Sell: 533,000 won Rose by 6,000 won compared to the previous trading day.
■ 14K Gold (3.75g) — Sell: 414,000 won Rose by 5,000 won compared to the previous trading day.
■ Platinum (3.75g) — Buy: 327,000 won / Sell: 273,000 won Both the purchase and selling prices rose by 3,000 won compared to the previous trading day.
■ Silver (3.75g) — Buy: 10,750 won / Sell: 10,250 won Both the purchase and selling prices rose by 100 won compared to the previous trading day.
■ Various Gold Investment Methods and Risks Gold investment currently offers a highly diverse range of methods. Investors have a wide array of options depending on their preferences, including direct purchase of physical assets such as gold bars and gold coins, installment-based investment through bank gold banking accounts, real-time tradable gold ETFs in the stock market, and investments in gold mining company stocks.
However, recent changes in global monetary policy and the emergence of profit-taking sell-offs have driven international gold prices below the $4,000-per-ounce mark, indicating that a sharp price correction is underway and requiring a cautious approach.
In particular, during periods of heightened volatility, even derivative products or financial investment products that are easy to access with small amounts can result in short-term losses larger than expected depending on market conditions. Therefore, experts point out that investors should carefully adjust their portfolio allocations in consideration of their personal investment tendencies and capital recovery periods.
[This article is by no means an investment solicitation. The content may merely represent opinions, so please do not use it as a reference or data for investment. All investments are made at the discretion of the individual, and the final responsibility lies with the investor. This publication assumes no responsibility whatsoever.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.


![Mixed Performance Across Bio and Pharma Stocks… Daewoong Pharmaceutical and SunBio Strong, Alteogen and Samchundang Pharm Weak [Market Summary]](https://media.cbcglobe.com/tenants/cbc00000-0000-4000-8000-000000000001/media/cbc/2026/06/579545/36de0fb87055dd02/variants/hero.webp)
